Rheumatic Disease & COVID-19 Vaccination: Why 55+ y/o Population Has a Better Response to the Vaccine? Are Immunosuppressed Patients at Risk for More Severe Outcomes?

By RheumNow FEATURING John J. Cush
By RheumNow FEATURING John J. Cush
0 views
January 13, 2021
Comments 0
Login to view comments. Click here to Login